Neurologic Examination (drug effects) And NotYves Agid
List of bibliographic references
Number of relevant bibliographic references: 15.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000362 | Valerie Cochen De Cock [France] ; Frederic Bourdain [France] ; Emmanuelle Apartis [France] ; Jean Marc Trocello [France] ; Emmanuel Roze [France] ; Marie Vidailhet [France] | Interictal myoclonus with paroxysmal kinesigenic dyskinesia |
| 000368 | Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 000471 | François Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease |
| 000538 | Marion Simonetta Moreau [France] ; Alexandra Séverac Cauquil [France] ; Marie Claude Costes Salon [France] | Static and dynamic balance function in spasmodic torticollis |
| 000569 | Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy |
| 000602 | Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France] | Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment |
| 000603 | Limousin [France] ; Pierre Pollak [France] ; Dominique Hoffmann [France] ; Abdelhamid Benazzouz [France] ; Jean Edmond Perret [France] ; Alim-Louis Benabid [France] | Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients |
| 000616 | Jean-Louis Montastruc [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; André Rascol [France] | Does fluoxetine aggravate Parkinson's disease? A pilot prospective study |
| 000627 | P. Krack [Allemagne] ; Marion [France] | “Apraxia of lid opening,” a focal eyelid dystonia: Clinical study of 32 patients |
| 000628 | J. L. Montastruc [France] ; N. Fabre [France] ; Olivier Rascol [France] ; J. M. Senard [France] ; O. Blin [France] | N‐methyl‐D‐aspartate (NMDA) antagonist and Parkinson's disease: A pilot study with dextromethorphan |
| 000629 | Rascol [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Janet Poulik [France] ; Umberto Sabatini [France] ; Jean-Michel Senard [France] ; Michèle Ané [France] ; Jean-Louis Montastruc [France] ; André Rascol [France] | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 000630 | Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 000639 | Fève [France] ; B. Angelard ; G. Fé Nelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-Guily | Postneuroleptic laryngeal dyskinesias: A cause of upper airway obstructive syndrome improved by local injections of botulinum toxin |
| 000644 | M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France] | Acute and long‐term response to apomorphine in cranial dystonia |
| 000647 | H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France] | Symptomatic effect of selegiline in De Novo Parkinsonian patients |
| This area was generated with Dilib version V0.6.23. |  |